Attention: Having Heart Surgery? At risk of Kidney Problems?


16307

A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects

Medicine

Brooks Charles, H

If you are scheduled to have heart surgery and your doctor has told you that you may be at risk for developing problems with your kidneys after surgery, you may be eligible to participate in a clinical research study to test an investigational drug, called AC607. The purpose of the study is to test AC607 to see if it can help people who have kidney injury after heart surgery. Currently there are no drugs available to treat kidney injury after heart surgery. Researchers at the University of Virginia in the Departments of Medicine and Surgery are working together with Allocure Inc, the sponsor of this study, to look for different treatment options. The study involves receiving an experimental drug or placebo and blood and urine tests to monitor your kidney function after heart surgery. Being a part of the study includes your time in the hospital, and follow up visits at 30 days, 90 days, 6 months, 12 months, 24 months, and 36 months after surgery. You may have additional visits to check your blood tests for kidney function which can be completed by a visiting home nurse. You may receive compensation for participating in this study. You will receive up to $500 for completion of all required visits in this study at the University of Virginia. The study drug and research required testing are provided at no charge to you or your insurance. Contact Information: For more information please contact: • Study coordinators at the Surgical Therapeutic Advancement Center • Telephone: 434-243-0315 • IRB-HSR # 16307 Principal Investigator: Charles Brooks, MD


Adult

Heart Disease (Coronary Artery Disease)
Kidney Injury/Disease Prevention

Nephrology (Kidney)
Surgery
Cardiology/Vascular

Ill

No Compensation

None None